Skip to main content
Clinical Trials/ACTRN12613000175774
ACTRN12613000175774
Recruiting
Phase 2

Prospective randomized clinical study of corticosteroids with surgery compared to surgery alone in patients with chronic subdural haematomas to reduce the reoccurence of chronic subdural haematomas (placebo-controlled double-blind study).

The Townsville Hospital0 sites100 target enrollmentFebruary 12, 2013

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Chronic Subdural Haematomas
Sponsor
The Townsville Hospital
Enrollment
100
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 12, 2013
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
The Townsville Hospital

Eligibility Criteria

Inclusion Criteria

  • All patients aged 18yrs or more with demonstrated chronic subdural haematoma (CSDH) (either on CT or MRI or both) that is considered by the admitting neurosurgical team to be the cause of the patient's presenting symptoms and/or signs, and to be amenable to neurosurgical management will be considered suitable for study. All patients with diabetes mellitus will be discussed with an endocrinologist prior to commencing corticosteroid (CS).

Exclusion Criteria

  • Children less than 18yrs will be excluded because the nature of CSDH in this group is entirely different to that observed in adults. Pregnant women will be excluded because CS can cause congenital malformations. Patients with a history of psychosis will be excluded because CS can provoke relapses.

Outcomes

Primary Outcomes

Not specified

Similar Trials